Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antibody Specificity | 1 | 2021 | 1328 | 0.63 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.51 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.40 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.38 | Why? |
| Immunoglobulins | 3 | 2019 | 811 | 0.37 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.34 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.34 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.33 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.29 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 6653 | 0.26 | Why? |
| Health Personnel | 4 | 2021 | 29646 | 0.24 | Why? |
| X Chromosome Inactivation | 1 | 2019 | 23 | 0.20 | Why? |
| Immunoglobulin Light Chains | 1 | 2019 | 62 | 0.19 | Why? |
| Chromosomes, Human, X | 1 | 2019 | 81 | 0.19 | Why? |
| Multiple Myeloma | 2 | 2019 | 1064 | 0.19 | Why? |
| Hematopoiesis | 1 | 2019 | 168 | 0.19 | Why? |
| Polysaccharides, Bacterial | 1 | 2018 | 59 | 0.18 | Why? |
| Private Sector | 1 | 2020 | 262 | 0.18 | Why? |
| Corylus | 1 | 2017 | 7 | 0.18 | Why? |
| Technology, Pharmaceutical | 1 | 2018 | 82 | 0.17 | Why? |
| Arachis | 1 | 2017 | 58 | 0.17 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.16 | Why? |
| Dried Blood Spot Testing | 1 | 2020 | 383 | 0.16 | Why? |
| Organ Specificity | 1 | 2021 | 1070 | 0.16 | Why? |
| Pollen | 1 | 2017 | 137 | 0.16 | Why? |
| Common Variable Immunodeficiency | 1 | 2019 | 195 | 0.16 | Why? |
| Saliva | 3 | 2021 | 4679 | 0.15 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.15 | Why? |
| Pneumococcal Vaccines | 2 | 2018 | 571 | 0.15 | Why? |
| Agammaglobulinemia | 1 | 2018 | 213 | 0.15 | Why? |
| Pneumonia, Pneumococcal | 1 | 2018 | 251 | 0.14 | Why? |
| United Kingdom | 8 | 2021 | 18046 | 0.14 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.13 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.13 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Food Hypersensitivity | 1 | 2017 | 397 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.11 | Why? |
| Allergens | 1 | 2017 | 728 | 0.11 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.10 | Why? |
| Vitamin D | 2 | 2021 | 2904 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
| Anaphylaxis | 1 | 2017 | 940 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.08 | Why? |
| Immunologic Memory | 1 | 2019 | 3362 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Adult | 7 | 2021 | 244371 | 0.06 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.06 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Taq Polymerase | 1 | 2021 | 31 | 0.06 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Vitamin D-Binding Protein | 1 | 2021 | 83 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Nut Hypersensitivity | 1 | 2017 | 6 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2019 | 501 | 0.04 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.04 | Why? |
| B-Lymphocyte Subsets | 1 | 2019 | 372 | 0.04 | Why? |
| Receptors, Androgen | 1 | 2019 | 212 | 0.04 | Why? |
| Immunoglobulins, Intravenous | 2 | 2020 | 2705 | 0.04 | Why? |
| Peanut Hypersensitivity | 1 | 2017 | 73 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2020 | 714 | 0.04 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.04 | Why? |
| Plant Proteins | 1 | 2017 | 194 | 0.04 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.04 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Immunophenotyping | 1 | 2019 | 1290 | 0.03 | Why? |
| DNA Methylation | 1 | 2019 | 688 | 0.03 | Why? |
| Immunoglobulin E | 1 | 2017 | 557 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2021 | 1074 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2019 | 1444 | 0.03 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Ireland | 1 | 2018 | 1456 | 0.03 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2020 | 1555 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2019 | 2742 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.02 | Why? |
| Cells, Cultured | 1 | 2019 | 5835 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2019 | 4849 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
Richter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(114)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_